SCHEMBL26175809

SCHEMBL26175809

c1ncc2cc(-c3c[nH]c4nc(C5CC5)ccc34)ccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 2/20 0.56
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ DYRK1A Q13627 8/20 0.38
▸ CAMKK2 Q96RR4 2/20 0.38
▸ EGFR P00533 2/20 0.36
▸ GSK3B P49841 2/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ DYRK1B Q9Y463 2/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CLK1 P49759 1/20 0.36
▸ CLK3 P49761 1/20 0.36
▸ DYRK2 Q92630 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ DYRK4 Q9NR20 1/20 0.36
▸ MAP3K11 Q16584 1/20 0.36
▸ FGFR4 P22455 1/20 0.36
▸ PIM1 P11309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175854 0.96 TDO2 (0.54) TDO2PIK3CDPIK3CADYRK1ACAMKK2
SCHEMBL26175893 0.96 TDO2 (0.54) TDO2PIK3CDPIK3CADYRK1ACAMKK2
SCHEMBL25519950 0.84 TDO2 (0.56) TDO2PIK3CDPIK3CADYRK1ACAMKK2
SCHEMBL26175807 0.83 DYRK1B (0.47) DYRK1ACAMKK2GSK3BTGFBR1DYRK1B
SCHEMBL26175731 0.81 TDO2 (0.60) TDO2PIK3CDPIK3CADYRK1AEGFR
SCHEMBL26175770 0.81 TDO2 (0.60) TDO2PIK3CDPIK3CADYRK1ACAMKK2
SCHEMBL26175808 0.81 DYRK1B (0.42) DYRK1ACAMKK2TGFBR1DYRK1BPIM1
SCHEMBL26176294 0.81 TDO2 (0.63) TDO2PIK3CDPIK3CADYRK1AGSK3B
SCHEMBL30406148 0.80 TDO2 (0.54) TDO2PIK3CDPIK3CADYRK1ACAMKK2
SCHEMBL25519952 0.80 TDO2 (0.54) TDO2PIK3CDPIK3CADYRK1ACAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 TDO2 764/4885PIK3CD 1228/4885PIK3CA 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback